Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Patient Eligibility for Participation in Surgery Clinical Trials
This study is currently recruiting participants.
Study NCT00019799   Information provided by National Cancer Institute (NCI)
First Received: July 11, 2001   Last Updated: July 7, 2009   History of Changes

July 11, 2001
July 7, 2009
August 1999
 
 
 
Complete list of historical versions of study NCT00019799 on ClinicalTrials.gov Archive Site
 
 
 
Study of Patient Eligibility for Participation in Surgery Clinical Trials
Evaluation for NCI Surgery Branch Clinical Research Protocols

RATIONALE: Evaluating patients for eligibility in clinical trials may help doctors plan more effective surgical treatment for patients who have cancer.

PURPOSE: This clinical trial is studying patients to determine if they are eligible for surgery clinical trials.

OBJECTIVES:

  • Evaluate patient eligibility for participation in NCI Surgery Branch protocols.
  • Permit standard therapy for patients ineligible for active Surgery Branch protocols who present novel or unique clinical training opportunity or conditions requiring immediate intervention in order to avoid compromising patient's health.

OUTLINE: Patients undergo various diagnostic procedures and clinical testing to determine protocol eligibility. The testing and procedures may include HLA blood typing, hepatitis screen, HIV serology, fine-needle aspiration, open incisional or excisional biopsies, leukapheresis, arteriogram, laparoscopy, various nuclear medicine and imaging scans with or without contrast dye, or pulmonary function tests.

PROJECTED ACCRUAL: A total of 5,000 patients will be accrued for this study within 5 years.

 
Interventional
Screening
Unspecified Adult Solid Tumor, Protocol Specific
Other: physiologic testing
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
5000
 
 

DISEASE CHARACTERISTICS:

  • Biopsy proven or suspected malignant disease

PATIENT CHARACTERISTICS:

Age:

  • 16 and over

Performance status:

  • Not specified

Life expectancy:

  • Not specified

Hematopoietic:

  • Not specified

Hepatic:

  • Not specified

Renal:

  • Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy

  • Not specified

Chemotherapy

  • Not specified

Endocrine therapy

  • Not specified

Radiotherapy

  • Not specified

Surgery

  • Not specified

Other

  • No concurrent therapy unless ineligible for Surgery Branch protocol and standard therapy deemed to be in best interest of patient and suitable for training needs of Surgery Branch staff
Both
16 Years and older
No
 
United States
 
NCT00019799
 
CDR0000067224, NCI-99-C-0128
National Cancer Institute (NCI)
 
Study Chair: Steven A. Rosenberg, MD, PhD NCI - Surgery Branch
National Cancer Institute (NCI)
July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP